2889
|
VA012
|
Positive allosteric modulator (PAM) of 5-HT2C receptor |
€105.00 |
3288
|
Vadadustat
|
Oral HIF-PH inhibitor and HIF stabilizer |
€80.00 |
2106
|
Valdecoxib
|
Selective COX-2 inhibitor |
€80.00 |
3722
|
Valemetostat
|
Inhibitor of Histone Lysine Methyltransferase EZH1/2 |
€160.00 |
3127
|
Valproic acid sodium salt
|
Anti-convulsant |
€50.00 |
3106
|
Valsartan
|
Potent, highly selective, and orally active AT1 antagonist |
€76.00 |
1411
|
Vandetanib
|
VEGFR and EGFR tyrosine kinase inhibitor |
€50.00 |
N0042
|
Vanoxonin
|
Strong thymidylate synthase inhibitor |
Inquire |
3396
|
Vardenafil dihydrochloride
|
Highly potent, selective and orally bioavailable inhibitor of cGMP-specific PDE5 |
€60.00 |
1384
|
Varenicline dihydrochloride
|
Nicotinic acetylcholine receptor agonist |
€80.00 |
2074
|
Varenicline tartrate
|
Selective α4β2 nicotinic acetylcholine receptor (nAChR) partial agonist |
€90.00 |
4077
|
Varespladib
|
sPLA2 inhibitor |
Inquire |
4032
|
Varespladib methyl
|
Secretory phospholipase A2 (sPLA2) inhibitor |
Inquire |
1867
|
Vasopressin antagonist 1867
|
Orally available and selective V1b receptor antagonist |
€150.00 |
1637
|
Vatalanib
|
VEGFR tyrosine kinase inhibitor |
€75.00 |
3519
|
VCP171
|
Positive allosteric modulator (PAM) of A1 receptors |
€120.00 |
1893
|
VE 821
|
Inhibitor of the DNA damage response kinase ATR |
€80.00 |
2452
|
VE 822
|
Selective ATR inhibitor that decreases survival of pancreatic cancer cells |
€110.00 |
1593
|
Veliparib
|
PARP inhibitor |
€40.00 |
2888
|
Veliparib dihydrochloride
|
PARP inhibitor |
€90.00 |
3173
|
Velpatasvir
|
Hepatitis C virus NS5A inhibitor |
€50.00 |
1727
|
Venlafaxine hydrochloride
|
SNRI |
€60.00 |
1608
|
VER 155008
|
Hsp70 inhibitor |
€95.00 |
3452
|
Verapamil hydrochloride
|
Ca2+ channel antagonist |
€50.00 |
2685
|
Vercirnon
|
CCR9 antagonist |
€135.00 |
3558
|
Vericiguat
|
Potent and orally available sGC stimulator |
€140.00 |
2938
|
Verinurad
|
Highly potent and selective inhibitor of the renal urate transporter URAT1 |
€95.00 |
3354
|
Verteporfin
|
Inhibitor of TEAD-YAP association; Photosensitizer |
€90.00 |
4166
|
Verubecestat
|
First-in-class, potent, orally bioavailable high-affinity BACE1 inhibitor |
€80.00 |
3585
|
Vesatolimod
|
Potent, selective and orally available TLR7 agonist |
€80.00 |